Preparing for the New Funding Model
Pharmaceutical Systems Strengthening and PSM
Lusaka, November 2013
Context
• 70-80% of the grants value in health commodities
• HIA2 countries more advanced PSM systems
• Impressive gains made in the last couple of years in building PSM
infrastructure (must keep momentum!)
• Increased demand (ART scale-up, change in guidelines, new
diagnostic technologies, expansion of treatment centers,
adherence support, QA, etc)
• More volumes to manage but constrained PSM systems (timely &
efficient procurement, storage in periphery, last mile distribution,
decentralization, coordination of pharmaceutical and laboratory
activities etc)
• NFM competing priorities – PSM/PSS needs visibility and support to
respond to program needs
Objective of the session
Discuss on:
• PSM preparations for the NFM
• Progress and challenges, support needed
• a roadmap for developing (or updating)
Pharmaceutical Sector Plan to inform future
investments
Principles of the new funding model
Principles
of the new
funding model
•
Bigger impact: focus on countries with the highest disease burden and
lowest ability to pay, while keeping the portfolio global
•
Predictable funding: process and financing levels become more
predictable, with higher success rate of applications
•
Ambitious vision: ability to elicit full expressions of demand and reward
ambition
•
Flexible timing: in line with country schedules, context, and priorities
•
More simple: for both implementers and the Global Fund
Preparing for the new funding model
5 areas to prepare for the new funding model
1
Plan ahead
2
Strengthen national strategies
3
Involve key groups
4
Consolidate information and use updated data
5
Ensure inclusion of PSM component in the Concept
Note
NFM: Health Product Management requirements
across the grant lifecycle
PSM arrangements
Procurement planning
1
Assumptions
NSP and standard treatment
guidelines
Procurement reviews, OSDV and
RSQA
3
2
Country
Dialogue
5
Assessment Tool
Concept
Note
Grant
making
Year 1
Year 2
Year 3
4
ADCD
PIP
•
•
•
PSM coordination mechanism
Health product management
Supply chain strategy/
Health Systems Strengthening
ADCD
Performance assessment
ADCD
Reporting
Health Product Management requirements:
Country Dialogue
PSM arrangement
assessment
Procurement planning
1
Assumptions
NSP and standard
treatment guidelines
Health products - related Requirements
• Mapping of PSM arrangements
• Mapping of Laboratory arrangements and capacity
• During the Country Dialogue these processes are to
be used as part of the foundation for Concept Note
development
Country
Dialogue
CT
Rationale
The Country Dialogue process is meant to ensure that requests to the Global
Fund:
• Are integrated into the broader disease strategy and National Strategy for
Pharmaceutical System Strengthening
• Build upon the lessons learned from past grant implementation
• Are inclusive and reflect inputs of diverse stakeholders, including the regulatory
authorities, supply chain stakeholders and lab authorities
Health products management requirements:
Concept Note
PSM arrangement
assessment
Procurement planning
2
Assumptions
NSP and standards
treatment guidelines
•
•
•
•
Concept note narrative
Programmatic gap tables
Modular tool
Pharmaceutical and Supply Chain and of National
Laboratory capacity – intervention areas
Concept
Note
Rationale
The Concept Note replaces the proposal process, and is a more iterative
process between the Secretariat and the CCM. Key differences include:
• Procurement plan is integrated in the modular tool
• PSM arrangements presented with system strengthening costed activity plan
Health Product Management requirements:
Grant Making
3
Grant
making
PSM-related Requirements
• Finalized estimated needs (quantification aligned
with program targets)
• Defined PSM arrangements to address the
systems gaps and sustain the delivery of products
Rationale
Grant-making is a process of collaboration between the Secretariat and the PR
to refine the Concept Note and translate it into a disbursement-ready grant.
• Refine details of activities and implementation to ensure they represent
value-for-money
• Customize grant activities to address identified capacity needs and/or risks
upfront rather than after grant signing
• Conduct comprehensive assessment of the PR using a single tool, rather
than multiple tools applied at different times during grant lifecycle
• Ensure appropriate selections of indicators and realistic target setting rather
than setting them prior to Secretariat review
PSM Preparation for the Concept Note
What to do between now and submission of the Concept Note?
Countries
Work on defining a Pharmaceutical System Strengthening Strategy (with costed
implementation plan and short/long term priorities) aligned with HSSP
Define the system for estimating health products’ requirements
Ask for TA and contact PSM Specialists in the Global Fund for guidance
Global Fund
Options for flexibilities (extensions and/or other provisions) to deal with
challenges related to timing
Country-specific discussions GF- Country Programs- Partners recognizing the
different country-specific situations
Support Countries to prepare for the Concept Note
Partners
TA in:
• Pharmaceutical System Strengthening (PSM optimization; RUM; QA;PV etc)
• Quantification for HIV, TB and Malaria medicines
Preparing for the new funding model
5 areas to prepare for the new funding model
1
Plan ahead
2
Strengthen national strategies
3
Involve key groups
4
Consolidate information and use updated data
5
Ensure inclusion of PSM component in the Concept
Note
Recap
1. PSM preparations for the NFM
- Start now. Identify with the CCM/PRs timelines for applying
- Do you have a Strategic Plan for PSM/PSS? Ready for funding?
- What are the immediate, medium and long term needs for investment?
2. Progress and challenges, support needed
- Did you evaluate recently your current state of the Pharmaceutical
System? Gaps identified? Evidence?
- If not enough evidence, ask for support (joint assessment by partners, TA,
knowledge sharing etc)
3. A roadmap for developing PSS to inform future investments.
- Nominate a working group; ask for support; think about TIMELINES!
- Consider working in parallel – Strategy for PSS aligned to HSSP, if time is
short, identify priority interventions in key areas.
- Make an action plan for interventions. Cost it! Identify contributions; Use it
in Concept Note! Finalize PSS strategy next.
Thank you
Let us discuss!